News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Replidyne, Inc. (RDYN) Says FDA Issues Warning Letter for Faropenem



1/29/2008 6:57:54 AM

Jan 28 (Reuters) - Replidyne Inc (RDYN.O: Quote, Profile, Research) said it received a warning letter from the U.S. Food and Drug Administration in regard to its antibiotic faropenem medoxomil 300 mg tablets twice per day dose.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES